Skip to Main Content

An official website of the United States government

Pre-diagnostic body mass index in relation to hormone receptor positive versus hormone receptor negative breast cancer incidence and mortality

Principal Investigator
Name
Omar Abdel-Rahman
Degrees
MD
Institution
Avicenna Oncology center
Position Title
Consultant and scientific director
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-432
Initial CDAS Request Approval
Dec 28, 2018
Title
Pre-diagnostic body mass index in relation to hormone receptor positive versus hormone receptor negative breast cancer incidence and mortality
Summary
Numerous studies have suggested a higher risk of breast cancer among patients with higher pre-diagnostic body mass index (BMI). However, little studies paid attention to the differential impact of BMI on hormone receptor positive versus hormone receptor negative breast cancer. Moreover, few studies evaluated the impact of BMI trajectory on breast cancer risk.
Aims

1. To evaluate the impact of pre-diagnostic BMI and BMI trajectory on breast cancer risk stratified by hormone receptor status

Collaborators

1. Dr. Omar Abdel-Rahman
1. Dr. Winson Cheung
2. Dr. Patricia Tang

Related Publications